Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characteristics of Non Diabetic Hyperglycemic Inpatients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00842010
Recruitment Status : Completed
First Posted : February 12, 2009
Last Update Posted : February 12, 2009
Sponsor:
Information provided by:
John H. Stroger Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

This retrospective nested non-matched case control study compared patients directly admitted to the General Medicine Wards, not transferred from ICU with

  • hyperglycemia on admission but no previous diagnosis of diabetes
  • diabetic hyperglycemic patients
  • non hyperglycemic non diabetic patients from the same nested population.

The investigators' hypothesis is that the clinical characteristics and endpoints of the non diabetic hyperglycemics should be similar to the diabetic population and different from the non diabetic non hyperglycemic population.


Condition or disease
Diabetes Mellitus

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 600 participants
Observational Model: Case-Control
Time Perspective: Cross-Sectional
Official Title: Hyperglycemic Non Diabetic (HND) Hospital Patients: Are They Different From Diabetic Hyperglycemic and Non-Hyperglycemic Non-Diabetic(NHND) Patients?
Study Start Date : March 2006
Actual Primary Completion Date : December 2007
Actual Study Completion Date : December 2008
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
HND
Patients with hyperglycemia, without previous diagnosis of diabetes
DH
Patients that have previous diagnosis of Diabetes Mellitus
NHND
Patient with NO previous diagnosis of diabetes, and no hyperglycemia


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Length of stay [ Time Frame: Measured 24 hours after patient is discharged. From day 1 of admission until day of discharge ]
  2. Inpatient Mortality [ Time Frame: From day 1 of admission until day of discharge ]

Secondary Outcome Measures :
  1. Frequency of SIRS on admission [ Time Frame: Measures obtained 24 hours after patient is discharged. Clinical data obtained on day 1 of admission ]
  2. Frequency of inpatient infection [ Time Frame: From day 1 of admission until day of discharge ]
  3. Rate of use of intravenous glucose drip [ Time Frame: From day 1 of admission until day of discharge ]
  4. Frequency of steroid use [ Time Frame: From day 1 of admission until day of discharge ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Nested sample obtained from patients admitted to John H. Stroger Jr. Hospital from March-April 2006 and in October 2007.
Criteria

Inclusion Criteria:

  • Admitted to John H. Stroger Jr. Hospital
  • Admitted to Internal Medicine Service from March-April 2006 and in October 2007

Exclusion Criteria:

  • Transfer from any intensive care unit (medical or surgical)
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00842010


Locations
Layout table for location information
United States, Illinois
John H. Stroger Jr. Hospital
Chicago, Illinois, United States, 60612
Sponsors and Collaborators
John H. Stroger Hospital
Investigators
Layout table for investigator information
Principal Investigator: Evelyn Lacuesta, MD John H. Stroger Jr. Hospital
Study Chair: Jyothsna Palla, MD John H. Stroger Jr. Hospital
Study Chair: Yannis Guerra, MD Rush University Hospital, John H. Stroger Jr. Hospital
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Evelyn Lacuesta, John H. Stroger Hospital
ClinicalTrials.gov Identifier: NCT00842010    
Other Study ID Numbers: HNDJHS200902
First Posted: February 12, 2009    Key Record Dates
Last Update Posted: February 12, 2009
Last Verified: February 2009
Keywords provided by John H. Stroger Hospital:
Diabetes
Inpatient
Hospital
Hyperglycemia